Ambien the Next Morning: Why Feeling Awake May Not Mean Driving Is Safe

“I feel fine, so I am fine.” It is the most common thing people tell themselves before driving after Ambien, and it is the belief the FDA has spent more than a decade trying to correct. The agency’s own words are blunt: people can be impaired the next morning even when they feel fully awake. The reason is not willpower or tolerance. It is how zolpidem, the drug in Ambien, behaves in the body and the brain.

This guide to driving after Ambien takes that myth apart piece by piece. You will see the blood-level data that drove the FDA to cut doses in 2013, five reasons your personal “am I okay?” check can mislead you, how the law treats prescription drugs behind the wheel, and a practical plan for mornings when you need to get somewhere.

The myth: “If I feel fine, I’m fine to drive”

Feeling alert is a real experience, and it is the main reason people trust themselves with driving after Ambien. Your eyes are open, coffee is working, and nothing seems off. The trouble is that sleepiness and impairment are not the same thing. Sleepiness is a feeling. Impairment is a measurable drop in reaction time, attention and steering control. Studies of sleep medicines keep finding the two can split apart: people feel normal while tests show they are not.

When the FDA lowered zolpidem doses in 2013, it did not simply add another line of warning text. It changed the dose itself, and it told patients directly that impairment can be present even when they feel fully awake. That choice says a lot. If a simple self-check reliably caught the problem, a warning would have been enough. The agency concluded it was not, so it reduced the amount of drug left in the blood by morning instead.

None of this means that everyone who takes Ambien is impaired every morning. Many people are not. The problem is that you cannot tell which group you are in on a given day just by checking how you feel.

What the FDA found in 2013, in plain words

Zolpidem has been on the US market since the early 1990s. For most of that time, the standard bedtime dose for adults was 10 mg for the immediate-release tablet and 12.5 mg for Ambien CR, the extended-release version. By 2013, the FDA had received roughly 700 reports of zolpidem linked to impaired driving or road accidents. That number alone did not prove cause, but it raised a question: how much zolpidem is still in the blood when people get up and drive?

To answer it, the FDA used two kinds of evidence. First, driving-simulator and clinical studies helped it pick a blood level at which driving impairment becomes likely. That level was about 50 nanograms per milliliter (ng/mL). Above it, the risk of impaired driving, and so of a crash, appeared to rise. Second, the agency looked at how many people still had zolpidem above that line about eight hours after a bedtime dose. Eight hours is a full night, the time most people assume is “enough.”

Here is what that analysis showed, as cited in a later review of the FDA action:

• With the old 10 mg immediate-release dose, about 15 out of every 100 women and about 3 out of every 100 men were still above 50 ng/mL eight hours later.
• With the old 12.5 mg extended-release dose, the numbers were higher: about 33 out of every 100 women and about 25 out of every 100 men.

Think of it this way. In a group of 100 women who took Ambien CR at the old dose and slept a full eight hours, about one in three would wake with a blood level linked to impaired driving. Most of them would have no idea.

The FDA acted in two steps. In January 2013, it told manufacturers to cut the recommended dose for women in half: 5 mg for immediate-release and 6.25 mg for extended-release. Prescribers were asked to think about the lower amounts for men as well. In May 2013, it approved the new labels and added a stronger line for Ambien CR: people taking either strength should not drive or do anything that requires full alertness the day after taking it.

For the full story of why women got a separate starting dose, see our companion piece on Ambien starting doses for women and men.

5 reasons your self-check fails when driving after Ambien

Each of these is a separate reason a “feels fine” test can mislead you about driving after Ambien. Several can stack on the same morning.

1. Impairment can exist without any feeling of it

The clearest proof comes from a sister drug. In 2014, the FDA reviewed a study of 91 healthy adults who took eszopiclone (Lunesta) 3 mg. Their driving, memory and coordination were impaired the next morning, most at 7.5 hours and still at 11.5 hours after the dose. Yet the volunteers’ own ratings of how sleepy they felt were often no different from placebo. The FDA noted that people were frequently unaware they were impaired. The Ambien labels make the same point: impairment can be present despite feeling fully awake.

2. Your sex changes how long zolpidem lingers

Women clear zolpidem more slowly than men. On the Ambien label, peak level and total exposure are about 45% higher in women at the same dose. On the Ambien CR label the gap is bigger: about 50% higher peak and 75% higher total exposure, with levels two to three times higher in women between 6 and 12 hours after the dose. That later window is exactly when most people are commuting.

3. The extended-release version is built to last longer

Ambien CR has two layers. One releases zolpidem right away and the other releases it more slowly to help you stay asleep. That second wave is useful at 3 a.m. and less welcome at 7 a.m. It is why the FDA singled out Ambien CR for a no-driving-the-next-day statement. Our sibling article on Ambien vs Ambien CR explains how the two tablets differ.

4. A short night or a middle-of-the-night dose shrinks the buffer

The standard Ambien label assumes you take it right before bed and have seven to eight hours before you need to wake up. Take it at 1 a.m. because you could not sleep, and you might be driving four or five hours later. A review of Dutch on-road driving studies led by Joris Verster found that regular zolpidem 10 mg and 20 mg, taken in the middle of the night, clearly impaired highway driving four hours later. The impairment was worse than what is seen at a blood alcohol level of 0.05%. By contrast, a low-dose 3.5 mg under-the-tongue tablet designed for night waking did not significantly impair driving at four hours.

Staying up after a dose is a related problem. If you took the pill and then stayed awake for a while, your sleep may be shorter than you think. Our Q&A on what happens if you take Ambien and stay awake explains why.

5. Extras you may not count: alcohol, other medicines, age and liver health

The Ambien label lists several things that raise the risk of next-day impairment, including impaired driving:

• Alcohol or other central nervous system depressants, such as opioids, benzodiazepines, some antidepressants and sedating antihistamines.
• Medicines that raise zolpidem levels by blocking the liver enzyme CYP3A4. The label notes itraconazole raised zolpidem exposure by about a third, and strong blockers like ketoconazole call for a lower zolpidem dose.
• A dose higher than recommended, including a second pill in the same night.
• Older age and liver disease. Older adults and people with mild to moderate liver problems start at 5 mg. In people with cirrhosis, zolpidem’s half-life stretched from about 2.5 hours to about 10 hours in label studies.

Curious how long the drug is detectable at all? Our guide on how long Ambien stays in your system covers detection windows, which is a different question from how long it affects driving.

Three mornings, three different answers on driving after Ambien

The same pill can lead to very different mornings. These three made-up examples show how the risk factors above combine in real life. They are not medical advice for any one person.

Dana, 52, Ambien CR 6.25 mg. Dana takes her tablet at 10:30 p.m. and her alarm goes off at 6:00 a.m. That is seven and a half hours, and she feels rested. But she takes the extended-release form, and the FDA’s advice for Ambien CR is to avoid driving the next day. She is also a woman, so her levels tend to run higher in the early-morning window. For Dana, driving after Ambien on a workday means a carpool or a talk with her prescriber about a different plan.

Marcus, 38, Ambien 5 mg immediate-release. Marcus takes his dose at 11:00 p.m., sleeps until 7:30 a.m., had no alcohol, and takes no other sedating medicines. His situation is closest to what the label assumes. Even so, the label tells him impairment can be present despite feeling awake. If he ever feels slow or foggy, he waits. If he notices a near miss, he stops driving and calls his prescriber.

Rosa, 70, Ambien 5 mg after a 2 a.m. wake-up. Rosa wakes at 2:00 a.m., cannot get back to sleep, and takes her regular tablet. She has a 7:00 a.m. appointment. That is five hours, well short of the seven to eight the label calls for, and older adults clear zolpidem more slowly. Based on the Dutch driving studies of middle-of-the-night zolpidem, this is a morning to get a ride or reschedule. Better still, she can ask her prescriber what to do on nights when she wakes early, so she is not making that choice half-asleep.

Notice that none of these decisions depend on how each person felt at breakfast. They depend on the dose, the timing and the person. That is the whole point of this article.

What about studies that found no impairment?

To be fair, not every study shows a next-morning problem. Some on-road tests found no driving impairment eight hours after a 10 mg immediate-release dose, in women or men. In 2019, David Greenblatt and colleagues reviewed the evidence and argued that the case for a separate women’s dose was weaker than the FDA suggested. The Ambien label itself reports that some next-day tests found no residual effects in younger adults with insomnia, while others found small drops in performance.

How do you square that with the FDA’s numbers on driving after Ambien? Averages hide the tails. A study can find that the group as a whole drove fine while a minority still had high blood levels. The FDA’s concern was that minority, because you cannot tell from the inside whether you are in it. That is why the agency combined lower doses with the advice to avoid driving when there is any doubt.

How next-day warnings compare across insomnia medicines

Ambien is not the only sleep medicine with morning-after concerns, and the rules for driving after Ambien are similar to those for its cousins. The table below compares what the labels and FDA safety notices say about next-day driving. It is meant for a conversation with your prescriber, not for choosing a drug yourself.

Medicine	How it is meant to be taken	What the FDA or label says about next-day driving	Key data point
Ambien (zolpidem, immediate-release)	Right before bed with 7 to 8 hours left in bed	Next-day impairment, including impaired driving, can occur; risk rises with a short night, higher dose, alcohol or interacting drugs	At the old 10 mg dose, about 15% of women and 3% of men were above 50 ng/mL at 8 hours
Ambien CR (zolpidem, extended-release)	Right before bed with 7 to 8 hours left; swallowed whole	Do not drive or do other activities needing full alertness the day after taking it (FDA, May 2013)	At the old 12.5 mg dose, about 33% of women and 25% of men were above 50 ng/mL at 8 hours
Edluar (zolpidem, under-the-tongue)	Right before bed with 7 to 8 hours left	Included in the 2013 FDA dose reduction alongside Ambien immediate-release	Same lower starting dose for women as Ambien immediate-release
Intermezzo (low-dose zolpidem, under-the-tongue)	Only for middle-of-night waking, with at least 4 hours left in bed	Do not take with less than 4 hours left; women already had a lower dose at approval in 2011	3.5 mg did not significantly impair on-road driving at 4 hours in Dutch studies
Lunesta (eszopiclone)	Right before bed with 7 to 8 hours left	Starting dose cut to 1 mg in May 2014; people on 3 mg should avoid next-day driving	3 mg caused impairment up to 11.5 hours, often without people noticing
Belsomra (suvorexant)	Within 30 minutes of bed with at least 7 hours left	People on 20 mg should be cautioned against next-day driving; lower doses can impair some people too	Some non-elderly adults showed meaningful driving impairment 9 hours after 20 mg

Two lessons stand out. First, every product on this list carries some next-day caution, so switching drugs is not a free pass. Second, the drugs designed to last longer through the night, and the higher doses, tend to carry the strongest morning warnings. For a deeper look at one of these comparisons, read our guide to Lunesta vs Ambien.

The legal side: can you get a DUI on Ambien?

Yes, you can. Driving after Ambien while impaired is treated like any other impaired driving. Impaired-driving laws in the United States cover more than alcohol and illegal drugs. The National Highway Traffic Safety Administration (NHTSA) puts it simply: drug-impaired driving is impaired driving, whether the drug was prescribed or not. Sleep aids are on NHTSA’s list of medicines that can make driving unsafe.

How the law applies depends on your state. A few patterns are common:

• Impairment-based laws. Every state lets police charge a driver who appears impaired by any substance. Officers may use field sobriety tests, a drug recognition evaluation, and a blood test.
• Zero-tolerance and per se laws. Some states also set a legal limit, or a zero limit, for certain drugs in the blood. These laws mostly target illegal drugs and cannabis, and how they treat prescription medicines varies from state to state.
• A prescription is generally not a shield. In general, having a valid prescription does not make impaired driving legal. Some states treat it as a possible defense in narrow cases, but that depends on local law. If you have legal questions, ask a lawyer in your state.

Beyond criminal charges, a crash after a sleeping pill can affect insurance claims and civil liability. The simplest protection is to not be behind the wheel when there is any doubt.

A practical plan for mornings after Ambien

You do not need to choose between sleep and getting to work. Safe driving after Ambien starts the night before. You need a plan that does not depend on how you feel at 7 a.m.

Before you take the pill

• Count the hours. Only take a bedtime zolpidem tablet if you can stay in bed for a full seven to eight hours. If you cannot, skip it that night and ask your prescriber what to do instead.
• Never redose. Do not take a second tablet the same night, even if the first one did not seem to work.
• Skip alcohol. The label says not to take Ambien if you drank alcohol that evening or before bed.
• Know your formulation. If you take Ambien CR, plan not to drive the next day, per the FDA’s 2013 advice.
• Mind the meal. A heavy meal can delay the drug’s onset and push its effects later. Our guide to taking Ambien with food explains why.

Getting where you need to go

• Line up other transportation for the mornings after you take it: a partner, carpool, transit, rideshare, or a later start time.
• If your job involves driving, operating machinery or safety-critical work, tell your prescriber. This may change which treatment is right for you.
• Do not “test” your driving after Ambien with a short trip around the block. A short drive carries the same risk per minute.

Questions to ask your prescriber

• Am I on the lowest dose that works for me? Would a lower starting dose make sense?
• Given my age, sex, liver health and other medicines, how long should I wait before driving?
• Is extended-release the right choice if I need to drive early in the morning?
• Would cognitive behavioral therapy for insomnia (CBT-I) let me use the medicine less often?

If something goes wrong

• If you notice drifting, near misses or missed exits after taking a sleeping pill, stop driving and call your prescriber.
• If you have driven, cooked or done other things at night with no memory of them, stop the drug and call your prescriber right away. Our post on Ambien sleepwalking and complex sleep behaviors explains what to do next.
• Report problems to FDA MedWatch at 1-800-FDA-1088. For a possible overdose or mix with alcohol, call Poison Control at 1-800-222-1222. In an emergency, call 911.

Your morning-after self-check is not a test

Takeaway on driving after Ambien

Driving after Ambien is not automatically dangerous, but it is never safe to judge by feel alone. The FDA’s own data showed that a meaningful share of people, especially women and people on extended-release zolpidem, still had impairing blood levels after a full night. Short nights, a middle-of-the-night dose, alcohol, interacting drugs, age and liver disease all add risk. The safest habit is to plan around the dose rather than your mood: take the lowest dose that works, only with a full night ahead, and have another way to get where you are going. When in doubt, wait or ride. Your prescriber can help you find a routine that protects both your sleep and the road.

The information here is educational and is not a substitute for personal medical or legal advice. Talk with your prescriber or pharmacist before changing how you take any sleep medicine, and check your own state’s laws on impaired driving. In an emergency, call 911.

Sources

• U.S. Food and Drug Administration. Questions and answers: Risk of next-morning impairment after use of insomnia drugs. 2013. fda.gov
• U.S. Food and Drug Administration. Drug Safety Communication: FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR. May 14, 2013. fda.gov
• U.S. Food and Drug Administration. Drug Safety Communication: FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose. May 15, 2014. fda.gov
• Ambien (zolpidem tartrate) and Ambien CR prescribing information, revised February 2022. Ambien; Ambien CR
• Belsomra (suvorexant) prescribing information, revised January 2020. accessdata.fda.gov
• Muzyk AJ, Harward JL, Clinard VB, et al. Impact of a US Food and Drug Administration Drug Safety Communication on zolpidem dosing: an observational retrospective cohort. Prim Care Companion CNS Disord. 2015;17(2). psychiatrist.com
• Verster JC, van de Loo AJ, Moline M, Roth T. Next-morning driving performance after middle-of-the-night administration of hypnotic drugs: evidence from Dutch on-road driving studies. Sleep. 2014;37. Utrecht University research portal
• Greenblatt DJ, Harmatz JS, Roth T. Zolpidem and gender: are women really at risk? J Clin Psychopharmacol. 2019;39(3):189-199. Henry Ford Health Scholarly Commons
• National Highway Traffic Safety Administration. Prescription and over-the-counter medicines (impaired driving campaign). nhtsa.gov